ARCHIVES

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

This article is from The Cancer Letter archive.

Vol. 17 No. 43 | November 8, 1991

Download PDF Visit The Full Archive

Related Articles

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997

In Brief: New Environmental Cancer Research Center Opened In Texas; Califano: No Promises

July 7, 1978

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979